查看完整行情页>>

|

货币单位:美元(USD)

Novan, Inc. (novn)

实时(?):
盘后(?):
读取中...
  • -- (--%)
开盘价:-- 最高价:-- 最低价:-- 52周最高价:-- 52周最低价:--
成交量:-- 平均成交量:-- 市值:-- 市盈率:-- 预期市盈率:--
每股收益:-- 贝塔系数:-- 股息:-- 收益率:-- 总股本:--
John M. Gay Presently, John M. Gay holds the position of Chief Financial & Accounting Officer & Secretary at Novan, Inc. Mr. Gay previously was Director-SEC Reporting at Maxpoint, Inc., Audit Senior Manager at Deloitte & Touche LLP, Audit Senior Manager at Arthur Andersen LLP, Director-SEC Reporting at Valassis Digital Corp. and Controller for Furiex Pharmaceuticals, Inc.
John A. Donofrio Presently, John A. Donofrio is Chief Operating Officer & Executive Vice President for Novan, Inc., Chief Financial Officer at Merz Pharmaceuticals LLC and Treasurer for Ulthera, Inc. He is also on the board of Aytu Biopharma, Inc., Children's Skin Disease Foundation and Alliance Medical Ministry. In the past Mr. Donofrio was Chief Financial Officer at TrialCard, Inc., Senior Finance Partner-US Business at GSK Plc and VP-US Specialty Global Finance & Puerto Rico at Stiefel Laboratories, Inc. (a subsidiary of GSK Plc), Principal at Edward Weck & Co., President at EPI Health LLC, Vice President-Operations & Controller at Arbor Pharmaceuticals LLC, Chief Financial Officer of Merz North America, Inc. and Principal at Fresenius Kabi AG. He received an undergraduate degree from North Carolina State University.
Brian M. Johnson Brian M. Johnson is Chief Commercial Officer of Novan, Inc. In his past career he held the position of President at REVIAN, Inc., Chief Commercial Officer of Novan, Inc., Principal at Two Hearts Group, LLC and Chief Digital Officer & VP-Prescription Marketing at Galderma Laboratories LP. He received an MBA from Southern Methodist University and an undergraduate degree from the University of Kansas.
Tomoko Maeda-Chubachi Tomoko Maeda-Chubachi is Chief Medical Officer at Novan, Inc. She previously held the position of Senior Medical Director at GSK Plc. She received a doctorate from Osaka University and an MBA from the University of Phoenix.
Andrew J. Novak Andrew J. Novak is Vice President-Accounting & Business Operations at Novan, Inc. In the past Mr. Novak was Director-Financial & SEC Reporting at SCYNEXIS, Inc., Audit Manager at Deloitte LLP (California) and Technical Manager at The American Institute of Certified Public Accountants. Mr. Novak received an undergraduate degree and a graduate degree from The University of North Carolina at Wilmington.
Carri Geer Presently, Carri Geer holds the position of Chief Technology Officer & Senior Vice President at Novan, Inc. She received a doctorate from The University of North Carolina at Chapel Hill.
Paula Brown Stafford Paula Brown Stafford is on the board of Health Decisions, Inc. and Alliance for Multispecialty Research LLC and Chairman, President & Chief Executive Officer at Novan, Inc. In the past Ms. Stafford held the position of President-Clinical Development at Quintiles Transnational Corp., President-Clinical Development at IQVIA, Inc., President-Clinical Development at IQVIA RDS, Inc., Chairman of Clinical Data Interchange Standards Consortium, Inc. and Adjunct Professor at The University of North Carolina at Chapel Hill. She received an undergraduate degree and a graduate degree from The University of North Carolina at Charlotte.
Steven D. Skolsky Steven D. Skolsky is on the board of Novan, Inc., Basilea Pharmaceutica AG, Elligo Health Research, Inc. and Kenan Flagler Business School Foundation and Global Head-Clinical & Data Operations at Quintiles Transnational Corp. and Member-Foundation Board at Kenan-Flagler Business School. In his past career he occupied the position of President & Chief Executive Officer of Sequoia Pharmaceuticals, Inc., SVP-Global Product Strategy & Clinical Development at GSK Plc Managing Director at GlaxoSmithKline NZ Ltd. Managing Director at GlaxoSmithKline Investments Pty Ltd. and Vice President-Sales & Marketing of Glaxo Wellcome, Inc. (which are all subsidiaries of GSK Plc), Principal at Expis Partners, Chief Executive Officer at Trimeris, Inc. and Head-Global Clinical Operations at Quintiles Transnational Holdings, Inc. He received an undergraduate degree from The University of North Carolina at Charlotte.
Robert J. Keegan Robert J. Keegan is a businessperson who has been the head of 6 different companies. Presently, he occupies the position of Chairman of Loparex, Inc. Mr. Keegan is also on the board of the University of Rochester, Novan, Inc., Autism Family Foundation and The Fuqua School of Business and Director-Heart Center at Duke University and Partner at L&K Properties of NC LLC. In the past Mr. Keegan was Executive Chairman for Goodyear Tire & Rubber Co., Chairman for Transtar Holding Co. LLC and Executive Chairman at Transtar Industries, Inc. (a subsidiary of Transtar Holding Co. LLC), Executive Vice President for Avery Dennison Corp., Executive Vice President at Eastman Kodak Co., Non-Executive Chairman of Xerox Corp., Chairman & Chief Executive Officer of Veyance Technologies, Inc. and Partner at FFL Partners LLC. Mr. Keegan received an MBA from the University of Rochester and an undergraduate degree from Le Moyne College.
John W. Palmour Founder of Wolfspeed, Inc., John W. Palmour is on the board of Novan, Inc. and Goodzer, Inc. In the past he occupied the position of Director & CTO-Advanced Devices at Wolfspeed, Inc. and Chief Technology Officer of Wolfspeed, Inc. (a subsidiary of Wolfspeed, Inc.). He received a doctorate and an undergraduate degree from North Carolina State University.
James L. Bierman James L. Bierman is on the board of Tenet Healthcare Corp., Novan, Inc., MiMedx Group, Inc. and KL Acquisition Corp. In his past career Mr. Bierman was President, Chief Executive Officer & Director at Owens & Minor, Inc., Chief Financial Officer, Director & Executive VP at Quintiles Transnational Corp. and Partner at Arthur Andersen LLP. Mr. Bierman received an undergraduate degree from Dickinson College and an MBA from Johnson Graduate School of Management.
A. Machelle Sanders A. Machelle Sanders occupies the position of Director & Secretary at The North Carolina Biotechnology Center and Secretary of The North Carolina Department of Commerce. Ms. Sanders is also on the board of BioCryst Pharmaceuticals, Inc. and Novan, Inc. In the past Ms. Sanders held the position of Vice President-Manufacturing & General Manager at Biogen, Inc., Vice President-Manufacturing & General Manager at Research Triangle Park and Secretary at North Carolina Department of Administration. A. Machelle Sanders received an undergraduate degree from North Carolina State University and a graduate degree from Pfeiffer University.